Abstract
The Molecular Profiling to Predict Response to Treatment (MP2PRT) program is part of the NCI's Cancer Moonshot Initiative. The aim of this program is the retrospective characterization and analysis of biospecimens collected from completed NCI-sponsored trials of the National Clinical Trials Network and the NCI Community Oncology Research Program. This study, titled "Identification of Genetic Changes Associated with Relapse and/or Adaptive Resistance in Patients Registered as Favorable Histology Wilms Tumor on AREN03B2", performs genomic characterization (WGS 30X, Total RNAseq, miRNAseq) on a discovery set of 70 trio cases (normal tissue, tumo
Catalogue metadata
- Record ID
- AISLI-R-D8DF770155177EC53EE3
- Type
- Datasets
- Source catalogue
- registry.opendata.aws
- الموضوع
- 生命科学与生物医学
- شروط الاستخدام
- [NIH Genomic Data Sharing Policy](https://gdc.cancer.gov/access-data/data-access-policies)